Atomoxetine Starting Dose and Optimal Timing
Start atomoxetine at 40 mg orally once daily in the morning for adults and children over 70 kg, or 0.5 mg/kg/day for children and adolescents up to 70 kg, and administer it as a single morning dose for optimal adherence and tolerability. 1, 2
Starting Dose Guidelines
Weight-Based Dosing
- For patients ≤70 kg: Initiate at 0.5 mg/kg per day (approximately 40 mg daily) 1
- For patients >70 kg (including adults): Start with 40 mg orally once daily 1, 2
- This conservative starting dose minimizes early adverse effects while establishing tolerability 1
Titration Schedule
- Maintain the initial 40 mg dose for at least 7-14 days before any dose increase to assess tolerability 1, 2
- After the initial period, increase to 60 mg daily, then if needed to 80 mg daily 1, 2
- Dose escalations should occur no more frequently than every 7-14 days to avoid behavioral activation, agitation, or other adverse effects 1
- The target therapeutic dose is 1.2 mg/kg/day (approximately 80 mg for most adults), which has demonstrated optimal efficacy 3
Maximum Dose Limits
- The maximum recommended dose is the lesser of 1.4 mg/kg/day or 100 mg/day 1, 2
- Doses exceeding this threshold do not improve efficacy and increase adverse-effect risk 1
- The 1.8 mg/kg/day dose provides no additional benefit over 1.2 mg/kg/day 3
Optimal Timing of Administration
Once-Daily Morning Dosing (Preferred)
- Administer atomoxetine as a single dose in the early morning 1, 2
- Once-daily morning dosing has been proven effective in controlled trials and improves medication adherence 3
- This timing minimizes potential sleep disturbances, as insomnia can occur with atomoxetine 2
Alternative Divided Dosing
- Atomoxetine can alternatively be given as divided doses in early morning and late afternoon/early evening if tolerability issues arise with once-daily dosing 3
- However, single morning dosing is generally preferred for simplicity and compliance 3
Critical Titration Principles
Slow Titration Rationale
- Gradual dose increases (smallest available increments at 1-2 week intervals) are better tolerated and help avoid exceeding the optimal dose 1
- Rapid dose escalation increases risk of behavioral activation/agitation, including motor restlessness, insomnia, impulsiveness, talkativeness, disinhibited behavior, and aggression 1
- Younger patients are more susceptible to behavioral activation with rapid dose increases 1
Response Timeline
- Atomoxetine requires 6-12 weeks to achieve full therapeutic effect, unlike stimulants which work within hours 1
- Setting appropriate patient expectations about this delayed response is essential to prevent premature discontinuation 1
Safety Monitoring Requirements
Mandatory Monitoring Parameters
- Monitor closely for suicidal ideation, clinical worsening, and unusual behavioral changes, especially during the first few months of treatment or after dose adjustments 1, 2
- Obtain baseline and monitor blood pressure, heart rate, height, and weight at follow-up visits 1
Common Adverse Effects
- Nausea, vomiting, fatigue, decreased appetite, abdominal pain, and somnolence are the most common side effects 1, 2
- These effects are generally mild to moderate and transient 4
- If side effects occur, consider returning to the previous well-tolerated dose 1
Clinical Pitfalls to Avoid
- Do not increase doses more frequently than every 7-14 days, as this significantly increases risk of behavioral activation 1
- Do not exceed 100 mg/day or 1.4 mg/kg/day, as higher doses provide no additional benefit and increase adverse effects 1
- Do not expect immediate symptom improvement—counsel patients that full effect takes 6-12 weeks 1
- Do not use atomoxetine as first-line therapy—it is recommended as second-line when stimulants fail or are not tolerated 1